Lipocine (LPCN) Tops Q2 EPS by 12c

Lipocine (NASDAQ: LPCN) reported Q2 EPS of ($0.32), $0.12 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $190 million versus the consensus estimate of $162.5 thousand.

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Faraday Future unveils nine robot models, prices start at $9,990
• SmartKem (SMTK) files for 15.13M share offering by selling stockholders
• U.S. and Denmark close in on a Greenland deal - Reuters